Page last updated: 2024-08-23

lirinidine and Carcinoma, Epidermoid

lirinidine has been researched along with Carcinoma, Epidermoid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chakka, AB; Chandran, U; Concha-Benavente, F; Faden, DL; Ferris, RL; McMichael, EL	1

Other Studies

1 other study(ies) available for lirinidine and Carcinoma, Epidermoid

Article	Year
Immunogenomic correlates of response to cetuximab monotherapy in head and neck squamous cell carcinoma. Head & neck, 2019, Volume: 41, Issue:8 Topics: Adult; Aged; Alkaloids; Antineoplastic Agents, Immunological; Carcinoma, Squamous Cell; Cell Line, Tumor; Cetuximab; Cohort Studies; Exome Sequencing; Female; Head and Neck Neoplasms; Histocompatibility Antigens Class I; HLA-A Antigens; HLA-C Antigens; Humans; Interferon-gamma; Killer Cells, Natural; Male; Middle Aged; Mutation; Receptors, KIR; Receptors, KIR3DL2; Signal Transduction; Up-Regulation	2019

Article

Year

Immunogenomic correlates of response to cetuximab monotherapy in head and neck squamous cell carcinoma.

Head & neck, 2019, Volume: 41, Issue:8

Topics: Adult; Aged; Alkaloids; Antineoplastic Agents, Immunological; Carcinoma, Squamous Cell; Cell Line, Tumor; Cetuximab; Cohort Studies; Exome Sequencing; Female; Head and Neck Neoplasms; Histocompatibility Antigens Class I; HLA-A Antigens; HLA-C Antigens; Humans; Interferon-gamma; Killer Cells, Natural; Male; Middle Aged; Mutation; Receptors, KIR; Receptors, KIR3DL2; Signal Transduction; Up-Regulation

2019